Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Iain C. Macdougall(King's College Hospital), Elena Zakharova(Ministry of Health of the Russian Federation), Yusuke Tsukamoto(Tufts Medical Center), Stefan D. Anker(Bayer (Germany)), Guy Rostoker, Jorge E. Toblli, Steven Fishbane(Northwell Health), Carol A. Pollock(The University of Sydney), Bruce Spinowitz, Itzchak Slotki, Christoph Wanner(Universitätsklinikum Würzburg), Glenn M. Chertow(Stanford Health Care), Tomas Ganz(University of California, Los Angeles), Elizabeta Nemeth(University of California, Los Angeles), Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), Ángel L.M. de Francisco, Peter Stenvinkel(Karolinska Institutet), Kamyar Kalantar‐Zadeh(University of California, Irvine), Amy Barton Pai(Vifor Pharma (Switzerland)), David Goldsmith(University College London), Gregorio T. Obrador(Universidad Panamericana), Chaim Hershko, Peter Bárány(Karolinska University Hospital), Ioav Cabantchik, Sandrine Gaillard(University Medical Center Utrecht), Daniel W. Coyne(Washington University in St. Louis), Francesca Tentori(DaVita Clinical Research (United States)), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alan J. Collins, Tadao Akizawa(Showa University), Francesco Locatelli(University of Modena and Reggio Emilia), Anatole Besarab(University of Virginia), Ewa A. Jankowska(Wroclaw Medical University), Jolanta Małyszko, Philip A. Kalra(University of Manchester), Dorine W. Swinkels(Radboud University Nijmegen), Sunil Bhandari(University of Hull), Jacques Rottembourg, Bertram L. Kasiske(University of Minnesota), Ajay Singh(Thapar Institute of Engineering & Technology), Ashraf Mikhail, Gert Mayer(Statistics Austria), Simon D. Roger(Gosford Hospital), John W. Adamson(University of Washington), Patrick S. Parfrey, Michael Auerbach, Kirsten L. Johansen, Der‐Cherng Tarng(National Yang Ming Chiao Tung University), Lawrence P. McMahon, Andreas J. Bircher(Università della Svizzera italiana), Günter Weiß(Innsbruck Medical University)
Cited by 474
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k